-+ 0.00%
-+ 0.00%
-+ 0.00%

BeOne Medicines Raises FY2026 Sales Guidance from $6.300B-$6.500B to $6.600B-$6.800B vs $6.479B Est

Benzinga·08/05/2026 10:00:41
Listen to the news
BeOne Medicines (NASDAQ:ONC) raises FY2026 sales outlook from $6.300 billion-$6.500 billion to $6.600 billion-$6.800 billion vs $6.479 billion estimate.